HUM
Humana Inc. NYSE Listed Dec 31, 1981$247.11
After hrs
$271.10
-1.40%
Mkt Cap $29.7B
52w Low $163.11
55.2% of range
52w High $315.35
50d MA $193.04
200d MA $240.72
P/E (TTM)
23.7x
EV/EBITDA
13.6x
P/B
1.6x
Debt/Equity
0.7x
ROE
6.1%
P/FCF
82.3x
RSI (14)
—
ATR (14)
—
Beta
0.45
50d MA
$193.04
200d MA
$240.72
Avg Volume
2.0M
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Humana Building · Louisville, KY 40202 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 9.97 | 10.31 | +3.4% | 243.12 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% | — |
| Feb 11, 2026 | TNS | -4.00 | -3.96 | +1.0% | 175.40 | -1.5% | +2.0% | +5.0% | +5.5% | +6.7% | +8.6% | — |
| Nov 5, 2025 | TNS | 2.93 | 3.24 | +10.6% | 264.94 | -1.2% | -5.2% | -4.9% | -10.0% | -8.1% | -9.2% | — |
| Jul 30, 2025 | TNS | 5.92 | 6.27 | +5.9% | 261.47 | -0.5% | -4.4% | -5.4% | -5.4% | -2.7% | -1.9% | — |
| Apr 30, 2025 | TNS | 10.07 | 11.58 | +15.0% | 262.24 | +0.7% | -2.4% | -1.4% | -2.1% | -4.0% | -3.5% | — |
| Feb 11, 2025 | TNS | -2.23 | -2.16 | +3.1% | 257.34 | +0.8% | +1.0% | -1.7% | -1.4% | -0.0% | +3.2% | — |
| Oct 30, 2024 | TNS | 3.40 | 4.16 | +22.4% | 266.32 | -3.3% | -3.2% | -2.1% | -4.0% | -2.1% | +8.3% | — |
| Jul 31, 2024 | TNS | 5.85 | 6.96 | +19.0% | 361.61 | -0.1% | -0.7% | +0.6% | -1.5% | -1.8% | -4.4% | — |
| Apr 24, 2024 | TNS | 6.12 | 7.23 | +18.1% | 315.98 | -0.4% | -1.4% | -3.2% | -4.1% | -4.4% | -0.6% | — |
| Jan 25, 2024 | TNS | -0.07 | -0.11 | -57.1% | 355.36 | -0.1% | +1.7% | +3.0% | +6.0% | +6.4% | +5.8% | — |
| Nov 1, 2023 | TNS | 7.16 | 7.78 | +8.7% | 489.36 | -1.0% | -1.6% | -2.5% | -0.4% | +1.8% | -0.2% | — |
| Aug 2, 2023 | TNS | 8.82 | 8.94 | +1.4% | 483.75 | -0.1% | +0.7% | +0.1% | +2.3% | +2.0% | +2.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | TD Cowen | Maintains | Hold → Hold | — | $236.44 | $237.76 | +0.6% | -1.2% | +0.6% | +1.3% | +4.2% | +4.5% |
| May 1 | JP Morgan | Maintains | Neutral → Neutral | — | $236.44 | $237.76 | +0.6% | -1.2% | +0.6% | +1.3% | +4.2% | +4.5% |
| Apr 30 | Evercore ISI | Maintains | In Line → In Line | — | $243.12 | $242.94 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% |
| Apr 30 | Guggenheim | Maintains | Buy → Buy | — | $243.12 | $242.94 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% |
| Apr 30 | UBS | Maintains | Neutral → Neutral | — | $243.12 | $242.94 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% |
| Apr 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $243.12 | $242.94 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% |
| Apr 30 | Truist | Maintains | Hold → Hold | — | $243.12 | $242.94 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% |
| Apr 30 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $243.12 | $242.94 | -0.1% | -2.7% | -3.9% | -2.1% | -1.5% | +1.3% |
| Apr 13 | Truist | Maintains | Hold → Hold | — | $192.15 | $191.00 | -0.6% | +3.2% | +2.1% | +3.2% | +4.5% | +6.8% |
| Apr 8 | Evercore ISI | Maintains | In Line → In Line | — | $197.15 | $199.47 | +1.2% | +0.6% | +0.1% | -2.5% | +0.5% | -0.5% |
| Apr 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $182.65 | $202.00 | +10.6% | +7.9% | +8.6% | +8.0% | +5.2% | +8.5% |
| Feb 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $174.64 | $177.80 | +1.8% | +0.8% | +7.0% | +9.1% | +7.2% | +4.0% |
| Feb 18 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $184.99 | $185.28 | +0.2% | +1.2% | +3.0% | +2.6% | -2.1% | -5.6% |
| Feb 17 | Goldman Sachs | Maintains | Sell → Sell | — | $184.10 | $184.28 | +0.1% | +0.5% | +1.6% | +3.5% | +3.1% | -1.6% |
| Feb 17 | Truist | Maintains | Hold → Hold | — | $184.10 | $184.28 | +0.1% | +0.5% | +1.6% | +3.5% | +3.1% | -1.6% |
| Feb 13 | TD Cowen | Maintains | Hold → Hold | — | $178.83 | $178.84 | +0.0% | +2.9% | +3.4% | +4.6% | +6.5% | +6.2% |
| Feb 12 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $175.40 | $172.70 | -1.5% | +2.0% | +5.0% | +5.5% | +6.7% | +8.6% |
| Feb 12 | Jefferies | Maintains | Buy → Buy | — | $175.40 | $172.70 | -1.5% | +2.0% | +5.0% | +5.5% | +6.7% | +8.6% |
| Feb 12 | UBS | Maintains | Neutral → Neutral | — | $175.40 | $172.70 | -1.5% | +2.0% | +5.0% | +5.5% | +6.7% | +8.6% |
| Feb 12 | Guggenheim | Maintains | Buy → Buy | — | $175.40 | $172.70 | -1.5% | +2.0% | +5.0% | +5.5% | +6.7% | +8.6% |
| Feb 12 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $175.40 | $172.70 | -1.5% | +2.0% | +5.0% | +5.5% | +6.7% | +8.6% |
| Feb 2 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $195.20 | $188.81 | -3.3% | -4.1% | -1.1% | -1.6% | -0.8% | -0.6% |
| Jan 7 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $279.84 | $276.56 | -1.2% | -1.7% | -0.8% | -1.1% | -1.2% | -2.1% |
| Jan 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $264.48 | $264.60 | +0.0% | +4.3% | +5.8% | +4.0% | +4.9% | +4.7% |
| Dec 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $260.28 | $259.30 | -0.4% | +0.1% | -0.3% | -1.0% | -1.2% | -0.4% |
| Dec 5 | Jefferies | Upgrade | Hold → Buy | — | $253.02 | $262.52 | +3.8% | +1.9% | +1.3% | -1.0% | +1.4% | +5.3% |
| Nov 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $229.20 | $228.40 | -0.3% | +3.8% | +7.3% | +7.2% | +5.7% | +5.6% |
| Nov 10 | Truist | Maintains | Hold → Hold | — | $252.04 | $248.14 | -1.5% | -5.4% | -3.4% | -4.6% | -6.1% | -5.9% |
| Nov 7 | Deutsche Bank | Maintains | Hold → Hold | — | $251.11 | $251.01 | -0.0% | +0.4% | -5.1% | -3.0% | -4.2% | -5.7% |
| Oct 10 | BofA Securities | Maintains | Neutral → Neutral | — | $290.60 | $285.97 | -1.6% | -3.6% | -6.7% | -10.0% | -9.8% | -8.0% |
| Oct 9 | Mizuho | Maintains | Outperform → Outperform | — | $298.04 | $301.02 | +1.0% | -2.5% | -6.0% | -9.1% | -12.2% | -12.0% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $295.20 | $298.29 | +1.0% | +0.0% | +1.0% | -1.6% | -5.1% | -8.2% |
| Oct 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $256.62 | $256.48 | -0.1% | +10.6% | +15.0% | +15.1% | +16.1% | +13.2% |
| Oct 3 | Guggenheim | Maintains | Buy → Buy | — | $256.62 | $256.48 | -0.1% | +10.6% | +15.0% | +15.1% | +16.1% | +13.2% |
| Sep 5 | Bernstein | Maintains | Outperform → Outperform | — | $312.00 | $311.46 | -0.2% | -1.3% | -0.5% | -12.5% | -12.3% | -10.7% |
| Sep 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $312.00 | $311.46 | -0.2% | -1.3% | -0.5% | -12.5% | -12.3% | -10.7% |
| Sep 2 | BofA Securities | Maintains | Neutral → Neutral | — | $303.66 | $304.59 | +0.3% | +2.1% | +2.7% | +2.7% | +1.4% | +2.2% |
| Aug 21 | RBC Capital | Maintains | Outperform → Outperform | — | $290.00 | $290.28 | +0.1% | +1.5% | +3.3% | +2.5% | +3.1% | +2.5% |
| Aug 14 | Argus | Maintains | Hold → Hold | — | $281.99 | $280.82 | -0.4% | -0.2% | +1.6% | +1.8% | +2.2% | +2.8% |
| Aug 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $281.99 | $280.82 | -0.4% | -0.2% | +1.6% | +1.8% | +2.2% | +2.8% |
| Jul 31 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $261.47 | $260.13 | -0.5% | -4.4% | -5.4% | -5.4% | -2.7% | -1.9% |
| Jul 31 | Piper Sandler | Maintains | Neutral → Neutral | — | $261.47 | $260.13 | -0.5% | -4.4% | -5.4% | -5.4% | -2.7% | -1.9% |
| Jul 31 | Barclays | Maintains | Equal Weight → Equal Weight | — | $261.47 | $260.13 | -0.5% | -4.4% | -5.4% | -5.4% | -2.7% | -1.9% |
| Jul 25 | Baird | Maintains | Neutral → Neutral | — | $229.21 | $231.10 | +0.8% | +3.8% | +1.0% | +1.5% | +14.1% | +9.0% |
| Jul 16 | Truist | Maintains | Hold → Hold | — | $221.90 | $222.50 | +0.3% | +2.1% | +0.7% | -0.7% | +0.7% | +4.2% |
| Jun 17 | Truist | Maintains | Hold → Hold | — | $235.39 | $234.44 | -0.4% | +2.6% | +3.4% | +1.8% | -0.3% | +1.4% |
| Jun 17 | BofA Securities | Maintains | Neutral → Neutral | — | $235.39 | $234.44 | -0.4% | +2.6% | +3.4% | +1.8% | -0.3% | +1.4% |
| Jun 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $231.74 | $230.59 | -0.5% | +1.4% | +1.5% | +1.6% | +4.2% | +5.0% |
| Jun 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $233.13 | $232.32 | -0.3% | -0.7% | +0.1% | -1.0% | -2.6% | -1.0% |
| May 12 | Truist | Maintains | Hold → Hold | — | $249.53 | $250.72 | +0.5% | +1.3% | -8.3% | -7.6% | -8.8% | -4.6% |
No insider trades available.
8-K
Humana Inc. -- 8-K Filing
Humana reported Q1 2026 earnings results, with detailed financial metrics and forward guidance provided during an earnings call to discuss quarterly performance and future expectations.
Apr 29
8-K
Humana Inc. -- 8-K Filing
Humana Inc. filed a current report on Form 8-K, indicating a material event requiring disclosure to shareholders and the SEC.
Apr 20
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The incomplete 8-K disclosure regarding an executive appointment at HCSG or HUM creates uncertainty about leadership changes, potentially signaling internal instability or succession planning complications that investors should monitor closely.
Apr 10
8-K · 1.01
! Medium
Humana Inc. -- 8-K 1.01: Financing / Debt Agreement
Humana secured a $1.0 billion financing agreement with Goldman Sachs, providing capital flexibility for operations, acquisitions, or debt management.
Mar 9
8-K · 7.01
! Medium
Humana Inc. -- 8-K 7.01: Regulation FD Disclosure
Humana will reaffirm its 2026 guidance of at least $8.89 diluted EPS and $9.00 adjusted EPS during investor meetings scheduled through March 31, 2026.
Mar 2
8-K
Humana Inc. -- 8-K Filing
Humana reported fourth-quarter and full-year 2025 financial results, with management providing guidance on future earnings expectations during an investor conference call.
Feb 11
Data updated apr 25, 2026 2:21pm
· Source: massive.com